Efgartigimod Provides Genuine Benefit For Myasthenia Gravis Disease Overview Efgartigimod, a neonatal Fc receptor inhibitor, has recently received approval for the treatment of myasthenia gravis (MG). This retrospective cohort study systematically evaluated the short- and long-term efficacy of efgartigimod in patients with refractory MG. Sixteen patients with autoimmune acetylcholine receptor MG, who
Tag: autoimmune disorder
Sjögren’s Disease Leads To Mental Health Meltdown
Sjögren’s Disease Leads To Mental Health Meltdown Overview Primary Sjögren’s syndrome (pSS) is a well-known autoimmune disorder characterized by inflammation of the glands, leading to symptoms such as dry eyes and mouth. While traditionally associated with peripheral glandular issues, Sjögren’s syndrome also impacts the central nervous system (CNS), manifesting in various neuropsychiatric
